Table 2.
Classification type I | Classification type II | |||||
---|---|---|---|---|---|---|
First function | Second function | First function | ||||
Standardized coefficient | Relative importance | Standardized coefficient | Relative importance | Standardized coefficient | Relative importance | |
RBC | 0.902 | −0.532* | 5.481 | 0.154 | 1.778 | 0.537* |
Hb | −1.362 | −0.332 | −5.723 | −0.410* | −2.225 | 0.284 |
MCV | 1.607 | 0.609 | 0.481 | −0.636* | 1.814 | −0.361* |
MCH | −0.257 | 0.292 | 2.408 | −0.788* | 0.152 | −0.529* |
RDW | 0.461 | 0.267 | 0.064 | 0.268 | 0.441 | 0.237 |
| ||||||
Proportion of trace (%) | 91.26 | 8.59 | 100 |
RBC: Red Blood Cells; Hb: hemoglobin; MCV: mean cell volume; MCH: mean cell hemoglobin; RDW: RBC distribution width.
First function: first linear discrimination function. Second function: second discrimination function. Classification type I: disease groups categorized into four diseases: mixed, β-thalassemia, α-thalassemia, and IDA. Classification type II: targeted diseases as genetic anemia (mixed, β- and α-thalassemia) and acquired anemia.
Standardized coefficient: standardized coefficient obtained from the linear discriminant analysis of each blood marker for the considered functions.
Relative importance: correlations of each variable with each discriminant functions.
*A correlation higher than 0.40 is considered significant.
Proportion of trace (%): proportion of variability of the outcome explained by the considered independent variables.